Mwanzo600196 • SHA
add
Shanghai Fosun Pharmaceutical (Group) Ord Shs A
Bei iliyotangulia
¥ 28.74
Bei za siku
¥ 28.08 - ¥ 29.05
Bei za mwaka
¥ 22.75 - ¥ 33.10
Thamani ya kampuni katika soko
72.78B CNY
Wastani wa hisa zilizouzwa
46.09M
Uwiano wa bei na mapato
23.14
Mgao wa faida
1.14%
Ubadilishanaji wa msingi
SHA
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (CNY) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 10.09B | -2.05% |
Matumizi ya uendeshaji wa biashara | 4.19B | 1.08% |
Mapato halisi | 937.21M | 52.38% |
Kiwango cha faida halisi | 9.28 | 55.44% |
Mapato kwa kila hisa | — | — |
EBITDA | 1.38B | -1.23% |
Asilimia ya kodi ya mapato | 15.49% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (CNY) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 15.64B | -2.87% |
Jumla ya mali | 118.83B | 2.85% |
Jumla ya dhima | 58.51B | 3.24% |
Jumla ya hisa | 60.32B | — |
hisa zilizosalia | 2.64B | — |
Uwiano wa bei na thamani | 1.60 | — |
Faida inayotokana na mali | 1.45% | — |
Faida inayotokana mtaji | 1.76% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (CNY) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 937.21M | 52.38% |
Pesa kutokana na shughuli | 1.08B | 8.96% |
Pesa kutokana na uwekezaji | -674.65M | 53.75% |
Pesa kutokana na ufadhili | -826.57M | -183.33% |
Mabadiliko halisi ya pesa taslimu | -422.05M | -181.71% |
Mtiririko huru wa pesa | 785.34M | -53.00% |
Kuhusu
Shanghai Fosun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International.
As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1994
Tovuti
Wafanyakazi
40,234
